FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine and pharmacology, and can be used to produce an agent form of gel for application anaesthesia in ophthalmic surgeries. Agent contains following components, wt%: hydroxyethyl cellulose 1.2–1.8, glycerol 17–25, lidocaine hydrochloride 1.8–2.4, chlorhexidine dihydrochloride 0.03–0.07, water- balance up to 100. Also disclosed is a method of application anaesthesia in ophthalmic surgeries.
EFFECT: group of inventions enables to produce an agent possessing antiseptic, optical-keratoprotective properties without preservatives, use of which enables to achieve complete anaesthesia with no complications.
4 cl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION FOR HYGIENIC TREATMENT OF THE EYELIDS | 2021 |
|
RU2778503C1 |
METHOD OF DETERMINING CORNEA PERMEABILITY | 2012 |
|
RU2500338C1 |
METHOD FOR ASSESSING MORPHOFUNCTIONAL STATUS OF MEIBOMIAN GLANDS - MEIBOMIAN GLANDS BIOMETRY | 2014 |
|
RU2567829C1 |
METHOD FOR TREATING NEUROTROPHIC HARE EYE KERATITIS CASES AGGRAVATED WITH CENTRAL OPTICAL CORNEA ZONE INJURY | 2005 |
|
RU2299048C2 |
MICRODIATHERMOPLASTY TECHNIQUE FOR TREATING INFECTIOUS CORNEAL ULCERS | 2011 |
|
RU2453296C1 |
METHOD FOR INTRODUCING DRUGS IN SUBSCLERAL WAY | 2003 |
|
RU2238709C1 |
VETERINARY HYGIENIC EYE LOTION | 2022 |
|
RU2785343C1 |
METHOD FOR TREATING COMPLICATED PURULENT CORNEAL ULCER | 2006 |
|
RU2309710C1 |
METHOD FOR COMPLEX THERAPY OF DYSFUNCTION OF THE MEIBOMIAN GLANDS | 2022 |
|
RU2790805C1 |
METHOD FOR PROLONGING ANTERIOR CHAMBER ANAESTHESIA AND PUPIL DILATATION EXPERIMENTALLY | 2013 |
|
RU2540007C1 |
Authors
Dates
2017-07-07—Published
2015-10-05—Filed